May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea , and cancer drug, Zaltrap.
Regeneron Pharmaceuticals , Inc . ( REGN ) May 20, 2013 10:00 am ET Executives Murray A. Goldberg ..... http://seekingalpha.com/article/1447681- regeneron - pharmaceuticals - inc -presents-at-ubs-global-healthcare-conference …
… GILD ) (up 50% YTD), Celgene ( CELG ) (up 57% YTD), Biogen Idec ( BIIB ) (up 55% YTD), and Regeneron Pharmaceuticals ( REGN ) (up 55% YTD) have all increased between 50 and 57% (see graph below). But is this divergence in …
PARIS, May 15 (Reuters) - French drugmaker Sanofi SA said it and U.S. firm Regeneron Pharmaceuticals have started recruiting patients for two new trials of their arthritis treatment sarilumab.
… Emerging Equities: Regeneron Pharmaceuticals (NASDAQ: REGN ), a mid-sized biotechnology ..... left in the stock. Regeneron Pharmaceuticals Inc . Regeneron is an integrated biopharmaceutical ..... first approved drug was Eylea (aflibercept), a …
… several significant drugs that support growth. Blockbuster eye disease drug Lucentis is witnessing intense competition from Regeneron 's Eylea , and while we expect the drug to hold its own, we doubt Lucentis will continue to serve as the growth driver it has been …
… Ivan Deryugin Since our original report on Regeneron Pharmaceuticals ( REGN ) in mid-December, shares of the company ..... to create a more favorable environment for Regeneron . And while REGN may be at all time highs, we believe that …
… Three short years ago, Regeneron Pharmaceuticals (NASDAQ: REGN ) was a $25 stock that seemed ..... Friday's (May 3rd) close, REGN closed at $266.16 - nearly ..... financials . Investors who bought Regeneron during the early clinical …
Regeneron Pharmaceuticals ( REGN ) Q1 2013 Earnings Call May 03 ..... Technology Committee and President of Regeneron Research Laboratories Robert J ..... seekingalpha.com/article/1399281- regeneron - pharmaceuticals -management-discusses-q1 …
Regeneron 's REGN first-quarter results ..... attractiveness of the Eylea franchise, which has ..... injections in wet AMD ( Eylea is dosed more frequently ..... to earnings. Strong Eylea growth helped push Regeneron even further into the …